Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

The treatment was ineffective in humans.

A rare ovarian tumor was successfully treated with surgery and chemotherapy.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Etretinate treatment changed hair growth patterns in many patients.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Tofacitinib is effective and safe for treating alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Certain cancer drugs can cause skin issues like rashes and itching.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

The treatment was effective and tolerable for advanced gastric cancer.